Sourcebio International Plc (SBI.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||||
| Income taxes - deferred | 3,971 | -201 | 116 | -60 |
| Accounts receivable | 3,228 | -5,245 | 1,306 | -727 |
| Other Working Capital | 9,443 | -8,020 | 346 | -141 |
| Other Operating Activity | 12,142 | 19,806 | 1,076 | 2,776 |
| Operating Cash Flow | $28,784 | $6,340 | $2,844 | $1,848 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,328 | 1,130 | -501 | -290 |
| Purchase Sale Intangibles | -40 | -140 | -80 | -45 |
| Investing Cash Flow | $-2,368 | $990 | $-581 | $-335 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 0 | 2,000 | 0 | 0 |
| Debt Repayment | 0 | -30,253 | -1,000 | -450 |
| Common Stock Issued | 0 | 35,003 | N/A | N/A |
| Other Financing Activity | -1,501 | -6,887 | -1,066 | -727 |
| Financing Cash Flow | $-1,501 | $-137 | $-2,066 | $-1,177 |
| Exchange Rate Effect | -46 | 7 | 0 | 0 |
| Beginning Cash Position | 8,435 | 1,235 | 1,038 | 702 |
| End Cash Position | 33,304 | 8,435 | 1,235 | 1,038 |
| Net Cash Flow | $24,915 | $7,193 | $197 | $336 |
| Free Cash Flow | ||||
| Operating Cash Flow | 28,784 | 6,340 | 2,844 | 1,848 |
| Capital Expenditure | -3,015 | -4,010 | -987 | -342 |
| Free Cash Flow | 25,769 | 2,330 | 1,857 | 1,506 |